www.tecoland.com
 
Ifosfamide bulk API

Tecoland supplies high purity Ifosfamide bulk Active Pharmaceutical Ingredient (API) produced by GMP facility. We custom package for orders ranging from milligram to bulk quantity. Welcome to contact us with your specific request.

 

The following information is provided for general information purposes ONLY.

 

Introduction of Ifosfamide

Ifosfamide is a clear fluid after being dissolved from powder with sterile water.

 

Side effects of Ifosfamide

Each person’s reaction to chemotherapy is unique. Some people have very few side effects, while others may experience more. The side effects described in this information will not affect everyone who is given ifosfamide, and may be different if you are having more than one chemotherapy drug.

We have outlined the most common and less common side effects, so you can be aware of them if they occur. However, we have not included those that are very rare and therefore extremely unlikely to affect you. If you notice any effects which you think may be due to the drug, but which are not listed in this information, please discuss them with your doctor or chemotherapy nurse.

Lowered resistance to infection  Ifosfamide can reduce the production of white blood cells by the bone marrow, making you more prone to infection. This effect can begin seven days after treatment has been given and usually reaches its lowest point 10–14 days after chemotherapy. Your blood cells will then increase steadily and will usually have returned to normal before your next course of chemotherapy is due.

Contact your doctor or the hospital straightaway if:

  • Your temperature goes above 38°C (100.5°F)
  • You suddenly feel unwell (even with a normal temperature)

You will have a blood test before having more chemotherapy, to make sure that your cells have recovered. Occasionally it may be necessary to delay your treatment if your blood count is still low.

Bruising or bleeding  Ifosfamide can reduce the production of platelets (which help the blood to clot). Let your doctor know if you have any unexplained bruising or bleeding.

Anaemia (low number of red blood cells) While having treatment with ifosfamide you may become anaemic. This may make you feel tired and breathless.

Nausea (feeling sick) and vomiting There are now very effective anti-sickness drugs to prevent or greatly reduce nausea and vomiting. If you do feel sick, it may begin a couple of hours after the treatment is given and last for up to a couple of weeks. If the sickness is not controlled or continues tell your doctor, who can prescribe other drugs which may be more effective.

Hair loss usually starts 3–4 weeks after the first dose of ifosfamide, although it may happen earlier. Hair may be lost completely or may just thin. You may also have thinning and loss of eyelashes, eyebrows and other body hair. This is temporary and the hair will regrow once the treatment ends.

Tiredness and a general feeling of weakness It is important to allow yourself plenty of time to rest.

Irritation of the bladder It is important to try to drink plenty of fluids to prevent any irritation. You will usually be given fluids into your vein before and after the chemotherapy is given. You may also be given a drug called mesna to protect the bladder and kidneys.

While you are having the chemotherapy you will be encouraged to pass urine every 3–4 hours during the day, and last thing at night. Your urine may be measured and tested for the presence of blood. If blood is present in the urine, further doses of mesna will be given.

Changes to nails Your nails may become ridged, but this change grows out over a few months once the treatment has finished.

Disclaimer:

Information on this page is provided for general information purposes. You should not make a clinical treatment decision based on information contained in this page without consulting other references including the package insert of the drug, textbooks and where relevant, expert opinion. We cannot be held responsible for any errors you make in administering drugs mentioned on this page, nor for use of any erroneous information contained on this page.